Intermittent Hypoxia Paired with High Intensity Training in Brain Injury
1 other identifier
interventional
35
1 country
1
Brief Summary
The central hypotheses are that HIT combined with AIH results in: 1) greater locomotor gains as compared to HIT alone; 2) improvements in gait quality and motor coordination during walking, and 3) changes in measures of community participation and integration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2020
CompletedFirst Posted
Study publicly available on registry
July 15, 2020
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedOctober 17, 2024
May 1, 2024
2.9 years
July 13, 2020
October 15, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change in gait speed
Gait speed is valid, reliable, and sensitive measures related to overall functional ability, and will be assessed by blinded rates. This measure will be performed by blinded assessors who do not participate in the training. Gait speed will be measured at self-selected speeds (SSS; instructions to "walk at normal comfortable pace") and fastest-possible speed (FS: "as fast as you safely can") using the Zeno Walkway (Protokinetics, Haverton, PA).
Baseline 1, Post 1 after 6 weeks, Baseline 2, Post 2 after 6 weeks
Change in Endurance
Endurance is valid, reliable, and sensitive measures related to overall functional ability, and will be assessed by blinded rates. This measure will be performed by blinded assessors who do not participate in the training. Gait endurance will be tested using the 6MWT (m) with instructions similar to SSS to minimize fall risk.
Baseline 1, Post 1 after 6 weeks, Baseline 2, Post 2 after 6 weeks
Secondary Outcomes (1)
Metabolic capacity
Baseline 1, Post 1 after 6 weeks, Baseline 2, Post 2 after 6 weeks
Study Arms (2)
High Intensity Training with Intermittent Hypoxia
EXPERIMENTALThe primary goal will be provide acute intermittent hypoxia (9% PO2; 1 min on 1 min off) prior to stepping training while maintaining HR within 70-85% maximum predicted HR (if patients are deconditioned, PTs will gradually increase intensity to desired levels as tolerated). Sessions will be divided into \~10 minute increments (\~25% of sessions) between speed-dependent treadmill training (described above for treadmill stepping), skill-dependent treadmill training, overground training, and stair climbing.
High Intensity Training with Sham Hypoxia
SHAM COMPARATORThe primary goal will be provide sham intermittent hypoxia (20% PO2) prior to performing continuous stepping while maintaining HR within 70-85% maximum predicted HR (if patients are deconditioned, PTs will gradually increase intensity to desired levels as tolerated). Sessions will be divided into \~10 minute increments (\~25% of sessions) between speed-dependent treadmill training (described above for treadmill stepping), skill-dependent treadmill training, overground training, and stair climbing.
Interventions
Acute intermittent treatment (AIH) will be initiated using an oxygen generator (Model HYP-123, Hypoxico Inc, New York, NY, and participants will be seated comfortably and fitted with a non-rebreather mask. AIH (using 9% O2) will be provided in 60 s intervals and repeated 15 times with alternating 60 s intervals of normoxia (21% O2). Continuous pulse oximetry (Masimo 7, Irvine CA) will be monitored to ensure oxygen saturation of 82-85%. Signs and symptoms of distress with AIH exposure will be noted throughout, with HR and blood pressure taken every 3-5 minutes and documented. High-intensity training will then be performed (40 min of walking training up to 70-80% maximum heart rate within 1 hr).
Sham acute intermittent treatment (sham AIH) will be initiated using an oxygen generator (Model HYP-123, Hypoxico Inc, New York, NY, and participants will be seated comfortably and fitted with a non-rebreather mask. Sham AIH (using 20% O2) will be provided in 60 s intervals and repeated 15 times with alternating 60 s intervals of normoxia (21% O2). Continuous pulse oximetry (Masimo 7, Irvine CA) will be monitored to ensure oxygen saturation of 82-85%. Signs and symptoms of distress with AIH exposure will be noted throughout, with HR and blood pressure taken every 3-5 minutes and documented. High-intensity training will then be performed (40 min of walking training up to 70-80% maximum heart rate within 1 hr).
Eligibility Criteria
You may qualify if:
- \> 6 months post brain injury
- years old
- ability to walk without physical assistance
- Self selected walking speed of 0.01-1.0 m/s
You may not qualify if:
- \<18 years old
- \>85 years old
- self selected walking speed of \> 1.0 m/s
- \< 3 months from botulinum toxin injection above the knee brace
- Currently receiving physical therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- Rehabilitation Hospital of Indianacollaborator
Study Sites (1)
Rehabilitation Hospital of Indiana
Indianapolis, Indiana, 46254, United States
Related Publications (1)
Hornby TG, Plawecki A, Lotter JK, Shoger LH, Voigtmann CJ, Inks E, Henderson CE. Acute Intermittent Hypoxia With High-Intensity Gait Training in Chronic Stroke: A Phase II Randomized Crossover Trial. Stroke. 2024 Jul;55(7):1748-1757. doi: 10.1161/STROKEAHA.124.047261. Epub 2024 Jun 11.
PMID: 38860389DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Hornby, PT,PhD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Blinding of both participant with actual vs sham treatment and blinding of primary outcome assessments
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Physcial Medicine & Rehabilitation
Study Record Dates
First Submitted
July 13, 2020
First Posted
July 15, 2020
Study Start
August 1, 2020
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
October 17, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
IPD available per request